Latest Ribonucleases Stories
--Novel Biologic Targets Innovative New Mechanism in Lupus-- SEATTLE, March 17, 2014 /PRNewswire/ -- Resolve Therapeutics, LLC announced today the initiation of clinical studies with
Human Argonautes (hAgo), are key proteins involved in a process known as RNA interference.
Researchers at the Whitehead Institute and Memorial Sloan-Kettering Cancer Center have defined and analyzed the crystal structure of a yeast Argonaute protein bound to RNA.
For years, RNA has seemed an elusive tool in nanotechnology researchâ€”easily manipulated into a variety of structures, yet susceptible to quick destruction when confronted with a commonly found enzyme.
- A volcanic mudflow.